Cours Reata Pharmaceuticals, Inc.
Actions
RETA
US75615P1030
Recherche biotechnologique et médicale
Dernier transcript sur Reata Pharmaceuticals, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director of Finance/CFO | 60 | 26/09/23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director/Board Member | - | 26/09/23 | |
Michael Dambach
BRD | Director/Board Member | - | 26/09/23 |
Nom | Poids | Encours | Varia. 1 janv. | Note Invest. |
---|---|---|---|---|
0,10% | 0 M€ | 0,00% | - | |
0,07% | 0 M€ | 0,00% | - | |
0,05% | 773 M€ | -.--% | - | |
0,04% | 509 M€ | -.--% |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |